110 related articles for article (PubMed ID: 38642324)
1. P2X7 receptor: a potential target for treating comorbid anxiety and depression.
Liu J; Liu TT; Mou L; Zhang Y; Chen X; Wang Q; Deng BL; Liu J
Purinergic Signal; 2024 Apr; ():. PubMed ID: 38642324
[TBL] [Abstract][Full Text] [Related]
2. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
[TBL] [Abstract][Full Text] [Related]
3. P2X7 Receptor Signaling in Stress and Depression.
Ribeiro DE; Roncalho AL; Glaser T; Ulrich H; Wegener G; Joca S
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174279
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
Lee S; Ha H; Jang J; Byun Y
Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
[TBL] [Abstract][Full Text] [Related]
5. Purinergic P2X7 receptor as a potential therapeutic target in depression.
Qi W; Jin X; Guan W
Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
[TBL] [Abstract][Full Text] [Related]
6. [Antidepressants].
Watanabe K
Brain Nerve; 2023 May; 75(5):573-578. PubMed ID: 37194534
[TBL] [Abstract][Full Text] [Related]
7. P2X7 receptor-mediated depression-like reactions arising in the mouse medial prefrontal cortex.
Ren WJ; Zhao YF; Li J; Rubini P; Yuan ZQ; Tang Y; Illes P
Cereb Cortex; 2023 Jul; 33(14):8858-8875. PubMed ID: 37183178
[TBL] [Abstract][Full Text] [Related]
8. Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists.
El Idrissi IG; Podlewska S; Abate C; Bojarski AJ; Lacivita E; Leopoldo M
Curr Med Chem; 2024; 31(11):1361-1403. PubMed ID: 37013427
[TBL] [Abstract][Full Text] [Related]
9. Gallic Acid Improves Comorbid Chronic Pain and Depression Behaviors by Inhibiting P2X7 Receptor-Mediated Ferroptosis in the Spinal Cord of Rats.
Yang R; Shi L; Si H; Hu Z; Zou L; Li L; Xu X; Schmalzing G; Nie H; Li G; Liu S; Liang S; Xu C
ACS Chem Neurosci; 2023 Feb; 14(4):667-676. PubMed ID: 36719132
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric activation of microglia in the hippocampus drives anxiodepressive consequences of trigeminal neuralgia in rodents.
Chen LQ; Lv XJ; Guo QH; Lv SS; Lv N; Xu WD; Yu J; Zhang YQ
Br J Pharmacol; 2023 Apr; 180(8):1090-1113. PubMed ID: 36443951
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles of the P2X7 receptor in cancer pain.
Wu P; Wang Y; Liu Y; Liu Y; Zhou G; Wu X; Wen Q
Purinergic Signal; 2023 Jun; 19(2):441-450. PubMed ID: 36400869
[TBL] [Abstract][Full Text] [Related]
12. P2X7 receptor in inflammation and pain.
Hu SQ; Hu JL; Zou FL; Liu JP; Luo HL; Hu DX; Wu LD; Zhang WJ
Brain Res Bull; 2022 Sep; 187():199-209. PubMed ID: 35850190
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
